神经重症卒中患者的共享决策:一项定性Meta整合
该定性Meta整合遵循乔安娜布里格斯研究所(JBI)方法学指南,采用Thomas和Harden的主题综合法,检索PubMed、CIHAHL、EMBASE、PsycINFO和Web of Science自建库至2023年7月的文献并辅以手工检索,初检获7,492篇,94篇全文筛选,最终纳入来自5个国家、2010年至2023年发表的18篇文章。这些研究聚焦共享决策过程,涵盖生命维持治疗、姑息治疗和临终关怀,其中生命维持治疗决策最常见。分析形成4个分析性主题、10个描述性主题:预后不确定性、多层面权衡、三方角色动态与信息交换、社会文化背景的影响,并据此构建概念模型。作者认为共享决策相关方之间复杂的角色动态需要审慎考虑,凸显卒中特异性沟通策略的必要性,并指出需在多元社会文化环境中扩展证据基础。
要点
- 纳入18篇来自5个国家、2010年至2023年发表的定性研究,聚焦神经重症卒中共享决策过程。
- 共享决策内容涵盖生命维持治疗、姑息治疗和临终关怀,其中生命维持治疗决策最常见。
- 形成4个分析性主题:预后不确定性、多层面权衡、三方角色动态与信息交换、社会文化背景的影响。
- 作者认为共享决策相关方之间复杂的角色动态需要审慎考虑,凸显卒中特异性沟通策略的必要性。
- 作者指出需在多元社会文化环境中扩展证据基础,以加深对神经重症卒中患者共享决策的理解。
适用人群与场景
- 神经重症监护中涉及共享决策的卒中患者及其相关方。
研究设计与关键结果
- 研究类型为定性Meta整合,遵循乔安娜布里格斯研究所(JBI)方法学指南,采用Thomas和Harden的主题综合法。
- 检索PubMed、CIHAHL、EMBASE、PsycINFO和Web of Science自建库至2023年7月的文献,并辅以手工检索;初检获7,492篇文章,94篇进入全文筛选。
- 最终纳入来自5个国家、2010年至2023年发表的18篇文章。
- 纳入研究聚焦共享决策过程,涵盖生命维持治疗、姑息治疗和临终关怀,其中生命维持治疗决策最常见。
- 分析形成4个分析性主题、10个描述性主题:预后不确定性、多层面权衡、三方角色动态与信息交换、社会文化背景的影响。
- 上述主题构成概念模型的基础,用以深入理解神经重症监护中共享决策的基本要素、关系和行为。
证据类型、等级与局限
- 证据类型:定性Meta整合(系统评价)。
- 方法学遵循乔安娜布里格斯研究所(JBI)指南,采用Thomas和Harden主题综合法,并使用JBI质量评价清单进行质量评价。
- 作者指出需在多元社会文化环境中扩展证据基础,以加深对神经重症卒中患者共享决策的理解。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为共享决策相关方之间复杂的角色动态需要审慎考虑,凸显卒中特异性沟通策略的必要性。
- 作者指出需在多元社会文化环境中扩展证据基础,以增强对神经重症卒中患者共享决策的理解。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Decision-making for patients with stroke in neurocritical care is uniquely challenging because of the gravity and high preference sensitivity of these decisions. Shared decision-making (SDM) is recommended to align decisions with patient values. However, limited evidence exists on the experiences and perceptions of key stakeholders involved in SDM for neurocritical patients with stroke. This review aims to address this gap by providing a comprehensive analysis of the experiences and perspectives of those involved in SDM for neurocritical stroke care to inform best practices in this context. A qualitative meta-synthesis was conducted following the methodological guidelines of the Joanna Briggs Institute (JBI), using the thematic synthesis approach outlined by Thomas and Harden. Database searches covered PubMed, CIHAHL, EMBASE, PsycINFO, and Web of Science from inception to July 2023, supplemented by manual searches. After screening, quality appraisal was performed using the JBI Appraisal Checklist. Data analysis comprised line-by-line coding, development of descriptive themes, and creation of analytical themes using NVivo 12 software. The initial search yielded 7,492 articles, with 94 undergoing full-text screening. Eighteen articles from five countries, published between 2010 and 2023, were included in the meta-synthesis. These studies focused on the SDM process, covering life-sustaining treatments (LSTs), palliative care, and end-of-life care, with LST decisions being most common. Four analytical themes, encompassing ten descriptive themes, emerged: prognostic uncertainty, multifaceted balancing act, tripartite role dynamics and information exchange, and influences of sociocultural context. These themes form the basis for a conceptual model offering deeper insights into the essential elements, relationships, and behaviors that characterize SDM in neurocritical care. This meta-synthesis of 18 primary studies offers a higher-order interpretation and an emerging conceptual understanding of SDM in neurocritical care, with implications for practice and further research. The complex role dynamics among SDM stakeholders require careful consideration, highlighting the need for stroke-specific communication strategies. Expanding the evidence base across diverse sociocultural settings is critical to enhance the understanding of SDM in neurocritical patients with stroke.Trial registration This study is registered with PROSPERO under the registration number CRD42023461608.
参考来源
- Zhang H, Davies C, Stokes D, et al. Shared Decision-Making for Patients with Stroke in Neurocritical Care: A Qualitative Meta-Synthesis. Neurocrit Care. 2024. PMID: 39192102. doi:10.1007/s12028-024-02106-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。